A full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants-Reference-Cited by-同舟云学术

A full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants

Published:2013-01 Issue:2 Volume:31 Page:373-379
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Bustamante Leyla Y.,Bartholdson S. Josefin,Crosnier Cecile,Campos Marta G.,Wanaguru Madushi,Nguon Chea,Kwiatkowski Dominic P.,Wright Gavin J.,Rayner Julian C.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference31 articles.

1. Vaccines against malaria;Hill;Philos Trans R Soc Lond B Biol Sci,2011

2. Malaria vaccine development: persistent challenges;Vaughan;Curr Opin Immunol,2012

3. Whole parasite vaccination approaches for prevention of malaria infection;Butler;Trends Immunol,2012

4. Vaccinating with the genome: a Sisyphean task?;Coppel;Trends Parasitol,2009

5. Gamma-globulin and acquired immunity to human malaria;Cohen;Nature,1961

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5;Cell;2024-09

2. Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype;Cell;2024-09

3. Leveraging Immunofocusing and Virus-like Particle Display to Enhance Antibody Responses to the Malaria Blood-Stage Invasion Complex Antigen PfCyRPA;Vaccines;2024-07-30

4. Immunogenicity of PvCyRPA, PvCelTOS and Pvs25 chimeric recombinant protein of Plasmodium vivax in murine model;Frontiers in Immunology;2024-06-19

5. Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex;Nature Communications;2024-06-07